Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04409639
Title Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations (CONCERTO)
Acronym CONCERTO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Utah
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Oregon Health and Science University RECRUITING Portland Oregon 97239 United States Details
Huntsman Cancer Institute at University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
Fred Hutchinson Cancer Research Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field